Chitosan composition
This invention relates to a cross-linkable chitosan composition comprising chitosan having a degree of deacetylation between 30 and 75%, wherein the chitosan is randomly deacetylated, and a cross-linking agent, wherein the molar ratio of the cross-linking agent to chitosan is 0.2:1 or less based on the number of functional groups in the cross-linking agent and the number of accessible amino groups in the chitosan. The invention also provides a chitosan hydrogel formed therefrom and uses thereof.
1. A viscoelastic hydrogel comprising a randomly deacetylated chitosan having a degree of deacetylation between 30 and 75%, wherein the chitosan is crosslinked with diethyl squarate at a molar ratio of the diethyl squarate to the chitosan of 0.2:1 or less based on the number of functional groups in the diethyl squarate and the number of deacetylated amino groups in the chitosan, and wherein the viscoelastic hydrogel is stable to processing into smaller, individually separated gel fragments.
2. A viscoelastic hydrogel as claimed in claim 1 , wherein the chitosan has a degree of deacetylation of between 35 and 55%.
3. A viscoelastic hydrogel as claimed in claim 1 or 2 , wherein the chitosan, prior to cross-linking, has a weight average molecular weight of 10-500 kDa.
4. A process for preparing a viscoelastic hydrogel of claim 1 comprising providing a randomly deacetylated chitosan in an aqueous solution, cross-linking the randomly deacetylated chitosan with diethyl squarate and isolating the resultant viscoelastic hydrogel.
5. A process as claimed in claim 4 , wherein the cross-linking is performed at a pH between 6 and 10.
6. A viscoelastic hydrogel obtained by the process of claim 4 or 5 .
7. A viscoelastic hydrogel as claimed in claim 6 in the form of a crushed gel.
8. A viscoelastic hydrogel as claimed in claim 6 for use as a vaccine, in drug delivery, in tissue augmentation, as a cell culture scaffold, for encapsulation of viable cells, in wound healing devices, in orthopaedics, as a biomaterial, for treating urinary incontinence or vesicoureteral reflux, in viscosurgery, in providing living cells to a host organism, as a cosmetic, as a bulking agent, as a thickener, as an additive in the food industry, as a glue, as a lubricants, or as a drilling servicing fluid.
9. A pharmaceutical composition comprising the viscoelastic hydrogel as claimed in claim 6 and a pharmaceutically active ingredient.
10. An immunological agent comprising the viscoelastic hydrogel as claimed in claim 6 and an antigen, wherein the antigen is optionally covalently bonded to the chitosan.